Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - heparin sodium (porcine mucous) - injection - 5000 iu/ml - heparin sodium (porcine mucous) 5000 iu/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - heparin sodium -

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - heparin sodium 5000 iu/ml (25.0 - 27.8 mg/ml);  ;   - solution for injection - 5000 iu/ml - active: heparin sodium 5000 iu/ml (25.0 - 27.8 mg/ml)     excipient: benzyl alcohol hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - heparin is indicated for the prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism and occlusive vascular disease. it is also used to prevent thromboembolic complications arising from cardiac and vascular surgery, frostbite, dialysis and other perfusion procedures. heparin is also used as an anticoagulant in blood transfusions.

India - English - Central Drugs Standard Control Organization

cfl ph. - mucopolysaccharide poly sulfate(heparinoid) - crm - 250iu/g - 5g/14g

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 5000 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism.unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 2500 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 2500 iu/ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections. cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - dalteparin sodium - injection - 25000 iu/ml - dalteparin sodium 25000 iu/ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - ropivacaine hcl - injection - 2 mg/ml - ropivacaine hcl 2 mg/ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - ropivacaine hcl - injection - 10 mg/ml - ropivacaine hcl 10 mg/ml